Table 3.
Q1 | Q2 | Q3 | Q4 | |||||
---|---|---|---|---|---|---|---|---|
OR (95%CI) | P value | OR (95%CI) | P value | OR (95%CI) | P value | OR (95%CI) | P value | |
NAFLD | ||||||||
Model 1 | Reference | 1.32 (1.13,1.54) | < 0.001 | 1.37 (1.18,1.60) | < 0.001 | 1.80 (1.54,2.10) | < 0.001 | |
Model 2 | Reference | 1.31 (1.12,1.54) | < 0.001 | 1.39 (1.18,1.63) | < 0.001 | 1.86 (1.57,2.19) | < 0.001 | |
Model 3 | Reference | 1.27 (1.05,1.53) | 0.015 | 1.26(1.04,1.53) | 0.017 | 1.81 (1.48,2.21) | < 0.001 | |
Advanced fibrosis | ||||||||
Model 1 | Reference | 1.43 (1.09,1.89) | 0.011 | 1.34 (1.02,1.77) | 0.035 | 1.67 (1.28,2.17) | < 0.001 | |
Model 2 | Reference | 1.46 (1.07,1.99) | 0.016 | 1.30 (0.96,1.77) | 0.092 | 1.73 (1,28,2.34) | < 0.001 | |
Model 3 | Reference | 1.45 (1.01,2.06) | 0.042 | 1.28 (0.90,1.83) | 0.169 | 1.46 (1.02,2.07) | 0.037 |
Model 1: no covariates were adjusted
Model 2: Age, gender and race were adjusted
Model 3: Age, gender, race, education level, PIR, smoking status, hypertension, diabetes was adjusted